News | November 12, 2014

High-risk Lung Cancer Patients More Likely to Receive Screening When Primary Care Provider Familiar With Guidelines

Results of more than 200 primary care providers indicate knowledge gap

November 12, 2014 — Patients at high-risk for developing lung cancer are more likely to receive low-dose computed tomography (LDCT) screening when their primary care provider is familiar with guideline recommendations for LDCT screening for lung cancer, according to research presented at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology. The symposium is sponsored by the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO), the International Association for the Study of Lung Cancer (IASLC) and The University of Chicago Medicine.

Lung cancer is the second most commonly occurring cancer and the leading cause of cancer-related death for both men and women in the United States. The use of LDCT screening for high-risk individuals has been recommended by several national healthcare organizations including the American Lung Association, the American College of Chest Physicians and the U.S. Preventive Services Task Force (USPSTF). High-risk patients, according to the December 2013 “Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement,” include adults ages 55 to 80 who have a 30 pack-year smoking history and who currently smoke or have quit within the past 15 years. Research has demonstrated that LDCT screening can lead to earlier diagnosis of lung cancer, thereby reducing lung cancer-specific mortality by 16 percent and increasing overall survival.

An online survey was sent to 488 primary care providers, including physicians, physician assistants and nurse practitioners, affiliated with the Wake Forest Baptist Medical Center in North Carolina, to identify their knowledge of, practice of and attitudes about lung cancer screening. The survey measured the provider’s use of lung cancer screening tests in the past year; the perceived effectiveness of LDCT screening in reducing lung cancer-specific mortality; knowledge of LDCT consensus guidelines; perceived barriers to LDCT screening; and interest in further education about LDCT screening for lung cancer.

Sixty percent (293) of the primary care providers responded. Of those respondents, 212 primary care providers cared for patients older than age 40 in the past year and were eligible for the study. Twenty-one percent (45) of respondents ordered a chest X-ray for lung cancer screening, and 12 percent (25) recommended LDCT for lung cancer screening, with an additional 3 percent (6) ordering sputum cytology (analysis of mucus from the lungs and airways).

The survey results showed that 48 percent (102) of respondents knew three or more of the six guideline components for LDCT screening, including who to screen, the recommended screening intervals and when to start or stop screening. Twenty-four percent (51) of providers that responded did not know any of the guideline components. Logistic regression analysis determined if providers’ knowledge of national guidelines influenced LDCT utilization. Providers who knew three or more of the guideline components were more likely to order LDCT screening for individuals at high-risk for developing lung cancer (Odds Ratio 5.0, 95 percent 1.9-12.9). Eighty percent (170) of the primary care providers responded that they were interested in more education about lung cancer screening.

Of the eligible respondents, 30 percent (64) were unsure of the effectiveness of LDCT in reducing cancer mortality, and none of these providers recommended LDCT for lung cancer screening for their patients.

The most commonly perceived barriers to LDCT screening according to survey respondents were patient cost (87 percent, n=184); potential harm from false positive findings (83 percent, n=176); patients’ lack of awareness (81 percent, n=172); potential harm from incidental findings (81 percent, n=172); and no insurance coverage (80 percent, n=170).

“The results of this survey highlight an essential need for provider education on the effectiveness of low-dose CT screening for lung cancer, on lung cancer screening guideline recommendations and the potential benefits and harms of screening,” said Jennifer Lewis, M.D., lead study author and an assistant chief of medicine in the department of internal medicine at Wake Forest Baptist in Winston-Salem, North Carolina. “It is also important to provide additional education for patients so that they can participate with their primary care provider in making informed decisions about lung cancer screening.”

For more information: www.astro.org

Related Content

Report Finds Identifying Patients for Lung Cancer Screening Not So Simple
News | Lung Cancer | June 18, 2018
New findings in the current issue of The American Journal of Managed Care suggest that getting the right patients to...
Weight-Bearing CT International Study Group Hosts  Scientific Session at AOFAS Conference
News | Computed Tomography (CT) | June 15, 2018
June 15, 2018 —The Weight-Bearing CT International Study Group will host a scientific session on the benefits of weig
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
360 Photos | 360 View Photos | June 14, 2018
This is a 360 degree image from the Canon Aquilion 64-slice...
American Society of Neuroradiology Honors Peter Chang with Cornelius G. Dyke Memorial Award
News | Neuro Imaging | June 13, 2018
Peter Chang, M.D., current neuroradiology fellow at UCSF and recently recruited co-director of the UCI Center for...
NewYork-Presbyterian Expands Mobile Stroke Treatment Unit Fleet

Image courtesy of NewYork-Presbyterian Hospital

News | Stroke | June 11, 2018
NewYork-Presbyterian, in collaboration with Weill Cornell Medicine, Columbia University Irving Medical Center and the...
Zebra Medical Vision Unveils AI-Based Chest X-ray Research
News | Artificial Intelligence | June 08, 2018
June 8, 2018 — Zebra Medical Vision unveiled its Textray chest X-ray research, which will form the basis for a future
Latest additions to Somatom go. CT platform address advanced clinical fields and applications, including cardiology, CT-guided intervention and dual energy CT. How to lower radiation dose from Computed tomography scanners using ned technology.

Latest additions to Somatom go. CT platform address advanced clinical fields and applications, including cardiology, CT-guided intervention and dual energy CT.

Feature | Computed Tomography (CT) | June 04, 2018 | By Melinda Taschetta-Millane
Recent studies show a rapid increase in patient radiation exposure mainly due to increased use of medical imaging, pa
Lung Decision Precision
News | Lung Cancer | June 04, 2018
For smokers and former smokers, the threat of lung cancer always lurks in the shadows.
Overlay Init